4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0001104659-22-073980
10% owner sold 101,903 shares at an average $12.80 ($1,304,816)
From the SEC's structured data for this filing
Trades in this filing
F2 Bioscience I 2017 Ltd · 10% owner
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-06-21 | Sale : show line 1 in the form | −22,319 | $12.77 | $284,929 | 616,976 | D |
| 2022-06-22 | Sale : show line 2 in the form | −49,953 | $12.70 | $634,578 | 567,023 | D |
| 2022-06-23 | Sale : show line 3 in the form | −29,631 | $13.00 | $385,310 | 537,392 | D |
| Open-market sales · 101,903 sh · avg $12.80 · $1,304,816 | ||||||
Loading xslF345X03/tm2219298-1_4seq1.xml…